Markel Group Inc. research snapshot
MKL AI stock analysis currently views Markel Group as a specialty-insurance-led holding company whose earnings also come from industrial, financial, and consumer businesses. At the July 11, 2026 data cutoff, the July 9 close reference was $1,949.44 and the verified market capitalization was about $24.39 billion. Markel Insurance produced a 93% combined ratio in the first quarter, while a $727.6 million net investment loss drove a reported operating loss. The current read is constructive on business quality but cautious on valuation and earnings volatility. This page is informational research, not investment advice.
Current price
$1,949.44 close reference on July 9, 2026
Market cap
$24.39 billion reported, with $24.388 billion from $1,949.44 times 12.51 million shares
AI score
72 / 100
Rating
Durable specialty insurer and diversified holding company, with sound underwriting and capital allocation but market-sensitive investment earnings
Trend status
Above the 50-day average but below the 200-day average as of the July 9, 2026 market reference
Data cutoff (updated weekly)
July 11, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Markel combines specialty insurance with independently operated industrial, financial, and consumer businesses. Customers pay Markel Insurance for risk transfer, underwriting expertise, claims capability, and financial strength. | High |
| Moat | The moat rests on specialty underwriting knowledge, broker relationships, licensing and capital, claims expertise, the Markel Style culture, investment float, and decentralized operating businesses. It is meaningful but must be renewed through underwriting discipline. | Medium-high |
| Management | Tom Gayner is CEO and has long led Markel investment activities. The key test is whether management continues to allocate insurance float, buybacks, acquisitions, and operating-company capital to improve long-term per-share value. | Medium-high |
| Financial trend | FY2025 operating revenue was $15.513 billion, up 5%, and net income to common shareholders was $2.081 billion. Q1 2026 adjusted operating income rose 4% to $497.7 million despite a reported operating loss from investment marks. | High |
| Valuation | At the July 9 reference price, exact arithmetic gives 14.06x TTM EPS, 1.35x book value, 11.15x free cash flow per share, and an 8.97% FCF yield. Insurance accounting and investment marks make a single earnings multiple incomplete. | Medium-high |
| Technical trend | MKL was above its 50-day moving average of $1,852.18 but below its 200-day moving average of $1,972.01. RSI was 60.02 and 20-day average volume was 80,956 shares. | Medium |
| Risk level | Risks include catastrophe losses, social inflation, reserve deterioration, investment-market losses, weaker insurance pricing, operating-company cyclicality, acquisition execution, and capital-allocation or governance pressure. | High |
| AI confidence | Reported financial data and valuation math are well supported by company disclosures and third-party market data. Technical levels and forecasts need refreshes as market conditions change. | High data confidence |
| Investment certainty | MKL is a quality-compounder candidate, but it is not a certainty because underwriting and investment results can diverge materially from a smooth long-term narrative. | Medium |
MKL AI stock forecast
The MKL AI stock forecast uses three-year scenarios, not a certain target. The exact model starts with $138.65 TTM EPS and the $1,949.44 July 9 reference. It produced sensitivity anchors near $1,265, $2,247, and $3,137 per share using bearish, base, and bullish earnings-growth and terminal-P/E assumptions.
$2,900 to $3,150
More likely if specialty underwriting remains disciplined, reserve development is favorable, the combined ratio stays attractive, investment income and equity values support results, Markel Ventures compounds, buybacks reduce shares, and investors accept a 17x terminal P/E.
$2,100 to $2,300
More likely if EPS compounds near 5% for three years, insurance profitability and investment income remain sound, operating businesses grow modestly, and the market applies a 14x terminal P/E. The exact model output was about $2,247.
$1,200 to $1,350
More likely if catastrophe or reserve losses rise, pricing softens, investment losses persist, Markel Ventures underperforms, capital allocation disappoints, or investors compress the multiple toward 10x earnings.
MKL AI technical analysis
MKL AI technical analysis uses the July 9, 2026 closing reference of $1,949.44. StockAnalysis reported a 50-day moving average of $1,852.18, a 200-day moving average of $1,972.01, RSI of 60.02, beta of 0.66, and 20-day average volume of 80,956 shares. The setup is constructive above short-term trend support but has not yet cleared longer-term trend resistance.
| Level | Value | Why it matters |
|---|---|---|
| Current price reference | $1,949.44 | July 9, 2026 closing reference used for valuation and market-cap verification. |
| Near support | $1,925 to $1,950 | The current price zone is the first area to monitor for a hold after a pullback. |
| Secondary support | $1,840 to $1,870 | This range contains the reported 50-day moving average near $1,852.18. |
| Deeper support | $1,720 to $1,750 | This zone aligns with the reported 52-week low of $1,719.41 and would require a fundamental review if reached. |
| Near resistance | $1,970 to $2,000 | The 200-day moving average near $1,972.01 is the first medium-term confirmation level. |
| Major resistance | $2,200 to $2,208 | The reported 52-week high of $2,207.59 is the key published overhead reference. |
| 50-day SMA | $1,852.18 | Trading above this average supports the shorter-term trend as of the data cutoff. |
| 200-day SMA | $1,972.01 | A sustained hold above this average would improve the medium-term technical read. |
| Momentum | RSI 60.02 | Momentum was positive but not extreme at the July 9 reference. |
| Volume | 80,956 shares | Use reported 20-day average volume to judge whether a move through resistance has support. |
| Volatility | Beta 0.66 | MKL has lower reported beta than the broad market, but insurance and portfolio events can still create sharp gaps. |
| Invalidation | Sustained close below $1,840 with weaker fundamentals | A break below the 50-day area alongside reserve, underwriting, or capital-allocation deterioration would weaken the setup. |
MKL AI trading strategy
This MKL AI trading strategy is a research and risk-control framework, not personalized investment advice. It combines technical confirmation with the insurance combined ratio, reserve development, investment results, book value, share repurchases, and the next reported earnings release.
Watch for MKL to hold above $1,925 to $1,950 and reclaim the 200-day moving average near $1,972 on credible volume, alongside stable underwriting results and no adverse reserve or investment surprise.
Treat a sustained close below the 50-day area near $1,852, especially with weaker fundamentals, as evidence that the setup has failed.
If MKL retraces toward $1,840 to $1,870, compare the lower quote with combined ratio, reserve commentary, invested assets, book value, repurchases, and the quality of operating-company earnings before assuming the stock is cheaper.
Do not average down just because the price falls. A lower price can reflect real deterioration in losses, marks, capital allocation, or the market view of Markel Ventures.
Track adjusted operating income, combined ratio, underwriting premium volume, net investment income, investment gains or losses, reserve development, book value per share, cash and invested assets, share repurchases, segment margins, and the July 29 earnings date listed by StockAnalysis.
Reassess the thesis after material reserve additions, catastrophe losses, weak pricing, persistent portfolio losses, a weaker balance sheet, or a capital allocation decision that does not improve long-term per-share value.
Investment research summary
Customers pay Markel Insurance for specialty risk transfer, underwriting judgment, claims capability, and financial strength. Markel also owns operating businesses that seek to produce independent cash flows and investment opportunities.
The moat comes from underwriting expertise, broker and client relationships, licenses and balance-sheet capacity, claims know-how, insurance float, a decentralized operating model, and a culture that prioritizes long-term returns. The moat is real but depends on avoiding undisciplined growth.
The thesis fails if Markel writes inadequately priced risk, reserves prove insufficient, catastrophe and social-inflation losses rise, investment marks or returns disappoint, operating businesses weaken, acquisitions dilute returns, or governance pressure pushes short-term actions over durable value creation.
Tom Gayner is CEO and the long-time investment leader. The management question is whether the Markel Style can keep underwriting, operating businesses, investments, repurchases, and acquisitions aligned around long-term per-share value rather than short-term reported earnings.
Complex commercial risks, specialist distribution, cyber and liability needs, and higher reinvestment yields can support specialty insurance over time. The industry remains cyclical because competition, loss-cost trends, litigation, climate events, and reinsurance capacity can change pricing quickly.
At the July 9 reference, exact calculations gave about 14.06x TTM EPS, 1.35x book value, and 11.15x free cash flow per share. Margin of safety depends on normalized underwriting and investment earnings, book-value compounding, and disciplined capital allocation, not on one quarter of GAAP investment marks.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| July 9 price, market cap, and shares outstanding | $1,949.44 close, $24.39B market cap, and 12.51M shares outstanding. Market cap arithmetic was verified with financial_rigor.py. | StockAnalysis MKL statistics and market cap pages | July 11, 2026 |
| FY2025 operating revenue | $15.513B, cross-validated with StockAnalysis financials | Markel Group 2025 financial results | July 11, 2026 |
| FY2025 net income to common shareholders | $2.081B, cross-validated with Macrotrends | Markel Group 2025 financial results | July 11, 2026 |
| FY2025 insurance and investment performance | $455.7M underwriting profit, 94.6% combined ratio, $970.4M net investment income, and $37.4B invested assets at year end | Markel Group 2025 financial results | July 11, 2026 |
| Q1 2026 results | $3.551B operating revenue, $497.7M adjusted operating income, $273.3M operating loss, 93% combined ratio, and $134M in repurchases | Markel Group Q1 2026 results | July 11, 2026 |
| TTM valuation and technical snapshot | $138.65 EPS, $1,440.23 book value per share, $174.81 FCF per share, 50-day SMA $1,852.18, 200-day SMA $1,972.01, RSI 60.02, and 20-day volume 80,956 shares | StockAnalysis MKL statistics and balance-sheet pages | July 11, 2026 |
| Investment and cash cross-check | $37.4B invested assets from Markel, compared with $37.439B total investments plus cash from StockAnalysis | Markel Group 2025 financial results and StockAnalysis balance sheet | July 11, 2026 |
This MKL AI stock analysis page is an informational research tool, not investment advice, a recommendation, or a guarantee of future returns. Forecast ranges are scenarios based on available public data, valuation assumptions, and technical snapshots as of the data cutoff, and they may be wrong.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
